Day: January 26, 2021

VANCOUVER, British Columbia, Jan. 25, 2021 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) is pleased to announce the voting results of the annual and special meeting of shareholders of the Company (the “Shareholders’ Meeting”) held in Vancouver, Canada on January 21, 2021. At the Meeting, the majority of the Company’s shareholders voted in favour of the following matters as set out in the Company’s management proxy circular dated December 9, 2020 (the “Circular”), a copy of which is available under the Company’s profile on SEDAR at www.sedar.com.The voting results are as follows:Appointment of Auditors – BDO Limited, Certified Public Accountants (Practicing), Hong Kong, was appointed as auditor of the Company to hold office for the ensuring year or until their successors are...

PALO ALTO, Calif., Jan. 25, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (the “Company,” “we” or “BridgeBio”) announced today the pricing of $650 million aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering (the “offering”) to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering was upsized from the previously announced offering of $400 million aggregate principal amount of notes. In connection with the offering, the Company granted the initial purchasers an option to purchase up to an additional $97.5 million aggregate principal amount of notes. The sale of the notes is expected to close on January 28, 2021, subject to customary closing conditions.The notes will bear interest at...

DAYTON BEACH, Fla., Jan. 25, 2021 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) (the “Company”) today announced the promotion of Stephen M. Boyd to the position of Executive Vice President and President of the Company’s Wholesale Brokerage Segment.Mr. Boyd most recently served as the Company’s Senior Vice President of Technology, Innovation, and Digital Strategy. He joined the Company’s subsidiary, Arrowhead General Insurance Agency, Inc., in 1995 and has served in various roles, including as Arrowhead’s President and Chief Operating Officer, President of Arrowhead’s Commercial Division, and Arrowhead’s Chief Information Officer. He has also served as a senior leader within Brown & Brown’s National Programs Segment.Anthony T. Strianese, who previously served as the President of the Company’s Wholesale Segment, has...

Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States.TORONTO, Jan. 25, 2021 (GLOBE NEWSWIRE) — COIN Hodl Inc. (TSXV: COIN) (“COIN”) is pleased to announce that it has entered into a letter of intent dated effective January 21, 2021 (the “LOI”) with Tokens.com Inc. (“Tokens”), a privately held Ontario corporation. The LOI sets out the general terms and conditions pursuant to which COIN has agreed to acquire all of the issued and outstanding securities of Tokens in exchange for securities of COIN (the “Transaction”).The Transaction will result in the reverse takeover of COIN by Tokens, as contemplated under the policies of the TSX Venture Exchange (the “Exchange”). COIN and Tokens are at arm’s length...

New York, NY, Jan. 25, 2021 (GLOBE NEWSWIRE) — Biotech Acquisition Company (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses, today announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. Although the Company may pursue a business target in any industry or geographic location, the Company intends to focus its search for a target business in the healthcare sector.The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “BIOTU” beginning January 26, 2021. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles...

DUBLIN, Ireland and BRIDGEWATER, N.J., Jan. 25, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN), announced today an expansion of the scope of its VASCEPA® (icosapent ethyl) cardiovascular (CV) risk reduction patent infringement lawsuit against Hikma Pharmaceuticals PLC to include a health care insurance provider in the United States, Health Net, LLC. The lawsuit was filed in the United States District Court in Delaware. A copy of the amended complaint is available through the FAQ section of the Amarin investor relations website.Multiple healthcare insurance providers and managed care enterprises have respected Amarin’s patent rights. As detailed in the complaint, Health Net is not among them. Through insurance coverage and economic incentives Amarin alleges that Health Net has actively induced pharmacies to dispense,...

PLAINVIEW, N.Y., Jan. 25, 2021 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its fourth quarter and full year 2020 financial results after the market closes on Thursday, February 11, 2021. The company will host a conference call to review these results starting at 5:00pm ET that day.To join the call, dial 1-866-248-8441 (toll free) or 1-929-477-0577 and use passcode 7940308. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco’s website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00pm ET that same evening.About VeecoVeeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our proven ion beam, laser annealing, lithography, MOCVD and single wafer etch & clean...

TULSA, Okla., Jan. 25, 2021 (GLOBE NEWSWIRE) — Educational Development Corporation (“EDC”, or the “Company”) (NASDAQ: EDUC) (http://www.edcpub.com) reports fiscal 2021 net revenue guidance in excess of $200.0 million and fiscal 2021 diluted earnings per share in excess of $1.45 per share.Per Randall White, Chief Executive Officer, “Recently we provided net revenues guidance for fiscal 2021 of approximately $200.0 million and earnings per share estimates between $1.40 and $1.50 per share. We are pleased to provide updated guidance results as we continue to improve through our fiscal fourth quarter. Having said this, I would like to reconfirm to our shareholders that there are significant variances in our quarterly performance results due to typical seasonality. Consequently, the Company evaluates quarterly and year to date results...